IGM Biosciences Inc (IGMS)

Currency in USD
1.28
-0.02(-1.54%)
Closed·
After Hours
1.280.00(0.00%)
·

IGMS Financial Summary

Key Ratios

P/E Ratio-1.49
Price/Book0.78
Debt / Equity6,298.14%
Return on Equity-47.82%
Dividend Yield0.00%
EBITDA-185.10M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of USD (except for per share items)

Analyst Ratings

0 Buy
4 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 1.12
(-12.23% Downside)

Earnings

Latest Release
May 08, 2025
EPS / Forecast
-0.75 / -0.352
Revenue / Forecast
499.50K / 3.36M
EPS Revisions
Last 90 days

FAQ

What were IGM Biosciences's earnings for the latest quarter?

The IGM Biosciences EPS (TTM) is -0.87. IGM Biosciences reported sales of 143.62, net income of 97.58, and EPS of -0.75 for the latest quarter.

What was IGM Biosciences's net income for the latest quarter?

IGM Biosciences's net income for the latest quarter was 97.58.

How did IGM Biosciences's performance compare year-over-year in the latest quarter?

The company's revenue moved from 0.50 in the previous quarter to 143.62 in the latest quarter, and net income moved from -52.89 to 97.58 compared to the previous quarter.

What is IGM Biosciences's net profit margin on a TTM basis?

IGM Biosciences's trailing twelve months (TTM) net profit margin is -7,308.51%.

How does IGM Biosciences's debt to equity ratio compare to industry standards?

IGM Biosciences's total debt-to-equity ratio is 6,298.14%.

What is IGM Biosciences's return on investment on a TTM basis?

IGM Biosciences's trailing twelve months (TTM) return on investment (ROI) is -47.82%.

Did IGM Biosciences gain or lose cash last quarter?

In the latest quarter, IGM Biosciences's net change in cash was -6.24 million.

What were IGM Biosciences's total assets and liabilities in the latest quarter?

As of the latest quarter, IGM Biosciences reported total assets of 106.99 million and total liabilities of 6.06 million.

How has IGM Biosciences's total revenue grown this year?

IGM Biosciences's total revenue was 0.50 in the previous quarter and 143.62 in the latest quarter.

What is IGM Biosciences's gross margin on a TTM basis?

IGM Biosciences's trailing twelve months (TTM) gross margin is -3.79%.

What was IGM Biosciences's revenue per share for the latest quarter?

IGM Biosciences's revenue per share for the latest quarter was 3.01.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.